Monte Rosa Therapeutics (GLUE) announced the appointment of Eric Hughes, M.D, Ph.D., to its Board of Directors. Dr. Hughes is currently Executive Vice President, Global R&D and Chief Medical Officer of Teva Pharmaceutical (TEVA)
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa announces closing of global license agreement with Novartis
- Monte Rosa Therapeutics presents preclinical data on CDK2 degrader
- Monte Rosa Highlights Promising Results in Cancer Study
- Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
- Monte Rosa Therapeutics Expands Pipeline with Novartis Deal